The increased connective tissue/fibrosis in MS vs. controls may therefore indicate decreased levels of TNFα/increased levels of TGFβ1, or at least a dysfunctional regulation of these cytokines compared to healthy controls. This evidence concerns the gene TNF and myeloid sarcoma.